Neural stem cells as engraftable packaging lines can mediate gene delivery to microglia: Evidence from studying retroviral env-related neurodegeneration

Journal of Virology

Volumn 73, Issue 8, 1999, Pages 6841-6851

  Lynch, William P ^a,b,c   Sharpe, Arlene H ^b   Snyder, Evan Y ^b,d  

^a Northeastern Ohio Medical University   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; STRUCTURAL PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; MICROGLIA; MOUSE; NERVE DEGENERATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RETROVIRUS; STEM CELL; VIRUS GENE;

EID: 0032789092     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.8.6841-6851.1999     Document Type: Article

References (65)

1. Andrews, J. M., and M. B. Gardner. 1974. Lower motor neuron degeneration associated with type C RNA virus infection in mice: neuropathological features. J. Neuropathol. Exp. Neurol. 33:285-307.
2. Austyn, J. M., and S. Gordon. 1981. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11:805-815.
3. Baszler, T. V., and J. F. Zachary. 1990. Murine retroviral-induced spongiform neuronal degeneration parallels resident microglial cell infection: ultrastructural findings. Lab Investig. 63:612-623.
4. Baszler, T. V., and J. F. Zachary. 1991. Murine retrovital neurovirulence correlates with an enhanced ability of virus to infect selectively, replicate in, and activate resident microglial cells. Am. J. Pathol. 138:655-671. (Erratum, 138:1058.)
5. Bender, M. A., T. D. Palmer, R. E. Gelinas, and A. D. Miller. 1987. Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region. J. Virol. 61:1639-1646.
6. Bestwick, R. K., S. L. Kozak, and D. Kabat. 1988. Overcoming interference to retroviral superinfection results in amplified expression and transmission of cloned genes. Proc. Natl. Acad. Sci. USA 85:5404-5408.
7. Brown, D. R., B. Schmidt, and H. A. Kretschmar. 1996. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature 380:345-347.
8. Czub, M., S. Czub, F. McAtee, and J. Portis. 1991. Age-dependent resistance to murine retrovirus-induced spongiform neurodegeneration results from central nervous system-specific restriction of virus replication. J. Virol. 65: 2539-2544.
9. Czub, M., F. J. McAtee, and J. L. Partis. 1992. Murine retrovirus-induced spongiform encephalomyelopathy: host and viral factors which determine the length of the incubation period. J. Virol. 66:3298-3305.
10. Czub, S., W. P. Lynch, M. Czub, and J. L. Portis. 1994. Kinetic analysis of the spongiform neurodegenerative disease induced by a highly virulent murine retrovirus. Lab. Investig. 70:711-723.
11. DesGroseillers, L., M. Barrette, and P. Jolicoeur. 1984. Physical mapping of the paralysis-inducing determinant of a wild mouse ecotropic neurotropic virus. J. Virol. 52:356-363.
12. Dickson, D. W., S. C. Lee, L. A. Mattiace, S.-H. C. Yen, and C. Brosnan. 1993. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7:75-83.
13. Evans, L. H., R. P. Morrison, F. G. Malik, J. Portis, and W. J. Britt. 1990. A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses. J. Virol, 64:6176-6183.
14. Gage, F. H. 1998. Cell therapy. Nature 392(Suppl.):18-24.
15. Gardner, M. B., B. E. Henderson, J. E. Officer, R. W. Rongey, J. C. Parker, C. Oliver, J. D. Estes, and R. J. Huebner. 1973. A spontaneous lower motor neuron disease apparently caused by indigenous type-C RNA virus in wild mice. JNCI 51:1243-1254.
16. Giulian, D., and M. Corpuz. 1993. Microglial secretion products and their impact on the nervous system. Adv. Neurol. 59:315-320.
17. Glass, J. D., and R. T. Johnson. 1996. Human immunodeficiency virus and the brain. Annu. Rev. Neurosci. 19:1-26.
18. Gordon, S., L. Lawson, S. Rabinowitz, P. R. Crocker, L. Morris, and V. H. Perry. 1992. Antigen markers of macrophage differentiation in murine tissues. Curr. Top. Microbiol. Immunol. 181:1-37.
19. Gravel, C., D. G. Kay, and P. Jolicoeur. 1993. Identification of the infected target cell type in spongiform myeloencephalopathy induced by the neurotropic Cas-Br-E murine leukemia virus. J. Virol. 67:6648-6658.
20. Hickey, W. F., K. Vass, and K. Lassmann. 1992. Bone marrow-derived elements in the central nervous system: an immunohistochemical and ultrastructural survey of rat chimeras. J. Neuropathol. Exp. Neurol. 51:246-256.
21. Jolicoeur, P., C. Gravel, and D. G. Kay. 1992. Pathogenesis of murine spongiform myeloencephalopathy induced by a murine retrovirus, p. 199-224. In R. P. Roos (ed.), Molecular neurovirology. Humana Press, Inc., Totowa, N.J.
22. Kay, D. G., C. Gravel, F. Pothier, A. Laperriere, Y. Robilalle, and P. Jolicoeur, 1993. Neurological disease induced in transgenic mice expressing the env gene of the Cas-Br-E murine retrovirus. Proc. Natl. Acad. Sci. USA 90:4538-4542.
23. Kozak, S. L., and D. Kabat. 1990. Ping-pong amplification of a retroviral vector achieves high level gene expression: human growth hormone production. J. Virol. 64:3500-3508.
24. Krall, W. J., P. M. Challita, L. S. Perlmutter, D. C. Skelton, and D. B. Krone. 1994. Cells expressing human glucocerebrosidase from a retroviral vector repopulate macrophages and central nervous system microglia after murine bone marrow transplantation. Blood 83:2737-2748.
25. Lacorraza, H. D., J. D. Flax, E. Y. Snyder, and M. Jendoubi. 1996. Expression of human β-hexosaminidase α-subunit gene (the gene defect of Tay Sachs disease) in mouse brains upon engraftment of transduced progenitor cells. Nat. Med. 2:424-429.
26. Lawson, L. J., V. H. Perry, and S. Gordon. 1992. Turnover of resident microglia in the normal adult mouse brain. Neuroscience 48:405-415.
27. Ling, E.-A., and W.-C. Wong. 1993. The origin and nature of ramified and amoeboid microglia: a historical review and current concepts. Glia 7:9-18.
28. Lynch, W. P., W. J. Brown, G. J. Spangrude, and J. L. Portis. 1994. Microglia infection by a neurovirulent murine retrovirus results in defective processing of envelope protein and intracellular budding of virus particles. J. Virol. 68:3401-3409.
29. Lynch, W. P, S. Czub, F. J. McAtee, S. F. Hayes, and J. L. Portis. 1991. Murine retrovirus-induced spongiform encephalopathy: productive infection of microglia and cerebellar neurons in accelerated CNS disease. Neuron 7:365-379.
30. Lynch, W. P., and J. L. Portis. 1993. Murine retrovirus-induced spongiform encephalopathy: disease expression is dependent on postnatal development of the central nervous system. J. Virol. 67:2601-2610.
31. Lynch, W. P., S. J. Robertson, and J. L. Portis. 1995. Induction of focal spongiform neurodegeneration in developmentally resistant mice by implantation of murine retrovirus-infected microglia. J. Virol. 69:1408-1419.
32. Lynch, W. P., and A. H. Sharpe. Unpublished data.
33. Lynch, W. P., E. Y. Snyder, L. F. Qualtiere, J. L. Portis, and A. H. Sharpe. 1996. Late virus replication events in microglia are required for murine retrovirus-induced spongiform neurodegeneration: evidence from neural progenitor-derived chimeric mouse brains. J. Virol. 70:8896-8907.
34. Martinez-Serrano, A., and A. Bjorklund. 1997. Immortalized neural progenitor cells for CNS gene transfer and repair. Trends Neurosci. 20:530-538.
35. McAtee, F. J., and J. L. Portis. 1985. Monoclonal antibodies specific for wild mouse neurotropic retrovirus: detection of comparable levels of virus replication in mouse strains susceptible and resistant to paralytic disease. J. Virol. 56:1010-1022.
36. McGeer, P. L., T. Kawamata, D. G. Walker, H. Akiyama, I. Tooyama, and E. G. McGeer. 1993. Microglia in degenerative neurological disease. Glia 7:84-92.
37. McKay, R. 1997. Stem cells in the central nervous system. Science 276:66-71.
38. Miller, A. D., and C. Buttimon. 1986. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6:2895-2902.
39. Miller, A. D., M. Law, and I. M. Verma. 1985. Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexateresistant dihydrofolate reductase gene. Mol. Cell. Biol. 5:431-437.
40. Morrison, S. J., N. M. Shah, and D. J. Anderson. 1997. Regulatory mechanisms in stem cell biology. Cell 88:287-298.
41. National Institutes of Health. 1985. Guide for the care and use of laboratory animals, rev. ed. Department of Health and Human Services publication no. (NIH) 85-23. National Institutes of Health, Bethesda, Md.
42. Perry, V. H., D. A. Hume, and S. Gordon. 1985. Immunohistochemical localization of macrophages and microglias in the adult and developing mouse brain. Neuroscience 15:313-326.
43. Portis, J. L., S. Czub, C. F. Garon, and F. J. McAtee. 1990. Neurodegenerative disease induced by the wild mouse ecotropic retrovirus is markedly accelerated by long terminal repeat and gag-pol sequences from nondefective Friend murine leukemia virus. J. Virol. 64:1648-1656.
44. Portis, J. L., S. Czub, S. Robertson, F. McAtee, and B. Chesebro. 1995. Characterization of a neurologic disease induced by a polytropic murine retrovirus: evidence for differential targeting of ecotropic and polytropic viruses in the brain. J. Virol. 69:8070-8075.
45. Portis, J. L., and W. P. Lynch. 1998. Dissecting the determinants of neuropathogenesis of the murine oncornaviruses. Virology 247:127-136.
46. Price, J., D. L. Turner, and C. L. Cepko. 1987. Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 84:156-160.
47. Rosario, C. M., B. D. Yandava, B. Kosaras, D. Zurakowski, R. L. Sidman, and E. Y. Snyder. 1997. Differentiation of engrafted multipotent progenitors towards replacement of missing granule neurons in meander tail cerebellum may help determine the locus of mutant gene action. Development 124: 4213-4224.
48. Ruscetti, S., D. Troxler, D. Unemeyer, and E. Scolnick. 1980. Three laboratory strains of spleen focus-forming virus: comparison of their genomes and translational products. J. Virol. 33:140-151.
49. Ryder, E. F., E. Y. Snyder, and C. L. Cepko. 1990. Establishment and characterization of multipotent neural cell lines using retrovirus vectormediated oncogene transfer. J. Neurobiol. 21:356-375.
50. Snyder, E., C. Yoon, J. Flax, and J. Macklis. 1997. Multipotent neural precursors can differentiate toward replacement of neurons undergoing targeted apoptotic degeneration in adult mouse neocortex. Proc. Natl. Acad. Sci. USA 94:11645-11650.
51. Snyder, E. Y. 1998. Neural stem-like cells: developmental lessons with therapeutic potential. Neuroscientist 4:408-425.
52. Snyder, E. Y., D. L. Deitcher, C. Walsh, S. Arnold-Aldea, E. Hartwieg, and C. L. Cepko. 1992. Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell 68:33-51.
53. Snyder, E. Y., and J. D. Flax. 1995. Transplantation of neural progenitors and stem like cells as a strategy for gene therapy and repair of neurodegenerative diseases. Ment. Retard. Dev. Disabil. Res. Rev. 1:27-38.
54. Snyder, E. Y., and M. Senut. 1997. Use of non-neural cells for gene delivery. Neurobiol. Dis. 4:69-102.
55. Snyder, E. Y., R. M. Taylor, and J. H. Wolfe. 1995. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature 374:367-370.
56. Snyder, E. Y., and J. H. Wolfe. 1996. CNS cell transplantation: a novel therapy for storage diseases? Curr. Opin. Neurol. 9:126-136.
57. Springer, T., G. Galfre, D. S. Secher, and C. Milstein. 1979. Mac-1: a macrophage diferentiation antigen identified by monoclonal antibody. Eur. J. Immunol. 9:301-306.
58. Springer, T., G. Galfre, D. S. Secher, and C. Milstein. 1978. Monoclonal xenogenic antibodies to murine cell surface antigens: identification of novel leukocyte differentiation antigens. Eur. J. Immunol. 8:539-551.
59. Stemple, D. L., and N. K. Manhanthappa. 1997. Neural stem cells are blasting off. Neuron 18:1-4.
60. Verma, I. M., and N. Somia. 1997. Gene therapy: promises, problems, and prospects. Nature 389:239-242.
61. Weiss, S., B. A. Reynolds, A. L. Vescovi, C. Morshead, C. Craig, and D. van der Kooy. 1996. Is there a neural stem cell in the mammalian forebrain. Trends Neurosci. 19:387-393.
62. Whittemore, S. R., and E. Y. Snyder. 1996. The physiologic relevance and functional potential of central nervous system-derived cell lines. Mol. Neurobiol. 12:13-38.
63. Wong, P. K. Y., and P. H. Yuen. 1992. Molecular basis of neurologic disorders induced by a mutant ts1, of Moloney murine leukemia virus, p. 161-197. In R. Roos (ed.), Molecular neurovirology: pathogenesis of viral CNS infections. Humana Press, Inc., Totowa, NJ.
64. Yu, Y. E., W. Choe, W. Zhang, G. Stoica, and P. K. Wong. 1997. Development of pathological lesions in the central nervous system of transgenic mice expressing the env gene of ts1 Moloney murine leukemia virus in the absence of viral gag and pol genes and viral replication. J. Neurovirol. 3:274-282.
65. env, and paralytogenesis. J. Virol, 54:364-373.